Epigenetic inhibitors and their role in cancer therapy
View/ Open
Publisher version (Check access options)
Check access options
Date
2023-01-01Author
Abdelaziz, NouhaTherachiyil, Lubna
Sadida, Hana Q.
Ali, Ateeque Mohamed
Khan, Omar S.
Singh, Mayank
Khan, Abdul Q.
Akil, Ammira S.Al Shabeeb
Bhat, Ajaz A.
Uddin, Shahab
...show more authors ...show less authors
Metadata
Show full item recordAbstract
Epigenetic modifications to DNA are crucial for normal cellular and biological functioning. DNA methylation, histone modifications, and chromatin remodeling are the most common epigenetic mechanisms. These changes are heritable but still reversible. The aberrant epigenetic alterations, such as DNA methylation, histone modification, and non-coding RNA (ncRNA)-mediated gene regulation, play an essential role in developing various human diseases, including cancer. Recent studies show that synthetic and dietary epigenetic inhibitors attenuate the abnormal epigenetic modifications in cancer cells and therefore have strong potential for cancer treatment. In this chapter, we have highlighted various types of epigenetic modifications, their mechanism, and as drug targets for epigenetic therapy.
Collections
- Pharmacy Research [1234 items ]